<DOC>
	<DOCNO>NCT02960464</DOCNO>
	<brief_summary>Investigation possible benefit transcranial direct current stimulation ( tDCS ) treatment depression patient Parkinson 's Disease , randomize placebo-controlled clinical trial .</brief_summary>
	<brief_title>tDCS Treatment Depression Parkinson 's Disease</brief_title>
	<detailed_description>We aim investigate effect transcranial direct current stimulation ( tDCS ) treatment depression patient Parkinson 's Disease . We design clinical trial volunteer fulfill inclusion criterion receive 15 session tDCS 1 week ( 3 session day , 30 minute interval ) . Subjects randomly allocate two group , one receive real intervention ( active ) receive placebo intervention ( sham ) . The collaborator charge administer session participate evaluation , keep subject evaluator blind nature session . Subjects evaluate baseline , end session , 1 week , 4 week 8 week , latter main outcome . We aim enroll 50 subject , 25 arm . The sample size calculation take consideration previous clinical trial use tDCS depression different setting .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Idiopathic Parkinson 's Disease Geriatric Depression Scale 15 high 5 Major Depression Disorder CNS disease Parkinson 's Disease ( i.e . epilepsy , stroke ) Mental disorder depression anxiety disorder ( i.e . bipolar disorder , schizophrenia ) Previous neurosurgical intervention ( i.e . DBS ) Current use antidepressant drug High suicidality risk Limited capacity understand write spoken Portuguese</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Parkinson Disease</keyword>
	<keyword>Depression</keyword>
	<keyword>Transcranial Direct Current Stimulation</keyword>
	<keyword>Neuromodulation</keyword>
</DOC>